Data / Form D filings / Inspira Technologies OXY B.H.N. Ltd
Inspira Technologies OXY B.H.N. Ltd: Form D filing
Inspira Technologies OXY B.H.N. Ltd, a biotechnology company in Ra'Anana, Israel, filed a Form D with the SEC in 2025. The latest, on January 7, 2025, reports $8.3 million sold of a $8.3 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2 HA-TIDHAR ST., Ra'Anana, Israel, 43665
- Phone
- 972-996-644-88
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1837493
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | New notice | $8,295,686 | $8,295,686 | 12 | Dec 27, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Limor Rozen | Director | |
| Dagi Ben-Noon | Executive Officer, Director | |
| Tal Parnes | Director | |
| Yafit Tehila | Executive Officer | |
| Daniella Yehezkely Hayon | Executive Officer | |
| Joe Hayon | Executive Officer, Director | |
| Lior Amit | Director | |
| Avi Shabtai | Executive Officer | |
| Benad Goldwasser | Director |
Every Form D from the week of Jan 6, 2025 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Inspira Technologies OXY B.H.N. Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.